The winner of the annual series between the Padres and Mariners will now win the Vedder Cup, a trophy designed by Pearl Jam ...

Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) is anticipated to release its earnings data before the market opens on Monday, March 17th. Analysts expect Abeona Therapeutics to post earnings of ...

STATEN ISLAND, N.Y. — A fundraising Polar Plunge to honor John Hudson Dilgen will take place this month in South Beach to ...

A revolutionary dressing that aims to repair the cells of people with an extremely painful skin condition and prevent infection is being investigated by Irish researchers. It was inspired by the ...

A young woman who appeared on the Late Late Show alongside Johnny Sexton has inspired a groundbreaking new dressing for ...

Carol Schober-Flores, BSN, RN, is a Mohs Surgical Nurse and Epidermolysis Bullosa Nurse Specialist, University Hospital, Denver, CO. Topical ointments can be applied directly over the Mepitel ...

The FDA has approved Krystal Biotech’s gene therapy Vyjuvek for dystrophic epidermolysis bullosa (DEB), a rare genetic disease characterised by fragile skin that can split and blister even with ...

The resubmission of the FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025 Company makes significant progress ...

Autoimmune bullous diseases are often associated with significant morbidity and some can even cause mortality, if left untreated. Multiple therapies are now available to treat these blistering ...

GENEVA, SWITZERLAND / ACCESS Newswire / March 6, 2025 /RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering ...